SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-001212
Filing Date
2019-03-14
Accepted
2019-03-14 07:31:40
Documents
74
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237988z10-k.htm 10-K 1266861
2 EX-23.1 a2237988zex-23_1.htm EX-23.1 3484
3 EX-31.1 a2237988zex-31_1.htm EX-31.1 7778
4 EX-31.2 a2237988zex-31_2.htm EX-31.2 7789
5 EX-32.1 a2237988zex-32_1.htm EX-32.1 4438
6 EX-32.2 a2237988zex-32_2.htm EX-32.2 4481
  Complete submission text file 0001047469-19-001212.txt   6376560

Data Files

Seq Description Document Type Size
7 EX-101.INS catb-20181231.xml EX-101.INS 1491519
8 EX-101.SCH catb-20181231.xsd EX-101.SCH 47511
9 EX-101.CAL catb-20181231_cal.xml EX-101.CAL 51762
10 EX-101.LAB catb-20181231_lab.xml EX-101.LAB 458169
11 EX-101.PRE catb-20181231_pre.xml EX-101.PRE 334027
12 EX-101.DEF catb-20181231_def.xml EX-101.DEF 168612
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37467 | Film No.: 19679737
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1